Effect of Lactobacillus paracasei CNCM I-1572 on symptoms, gut microbiota, short chain fatty acids, and immune activation in patients with irritable bowel syndrome: A pilot randomized clinical trial

Consumption of a Bifidobacterium bifidum Strain for 4 Weeks Modulates Dominant Intestinal Bacterial Taxa and Fecal Butyrate in Healthy Adults

(2016) Giorgio Gargari et al.   APPLIED AND ENVIRONMENTAL MICROBIOLOGY

The Intestinal Microenvironment and Functional Gastrointestinal Disorders

(2016) Giovanni Barbara et al.   GASTROENTEROLOGY

Design of Treatment Trials for Functional Gastrointestinal Disorders

(2016) E. Jan Irvine et al.   GASTROENTEROLOGY

Bowel Disorders

(2016) Brian E. Lacy et al.   GASTROENTEROLOGY

Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health

(2016) David Ríos-Covián et al.   Frontiers in Microbiology

Intestinal Microbiota And Diet in IBS: Causes, Consequences, or Epiphenomena?

(2015) Mirjana Rajilić-Stojanović et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Efficacy of Prebiotics, Probiotics and Synbiotics in Irritable Bowel Syndrome and Chronic Idiopathic Constipation: Systematic Review and Meta-analysis

(2014) Alexander C Ford et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Modulation of Fecal Clostridiales Bacteria and Butyrate by Probiotic Intervention with Lactobacillus paracasei DG Varies among Healthy Adults

(2014) Chiara Ferrario et al.   JOURNAL OF NUTRITION

The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic

(2014) Colin Hill et al.   Nature Reviews Gastroenterology & Hepatology

Randomised clinical trial: mesalazine and/or probiotics in maintaining remission of symptomatic uncomplicated diverticular disease - a double-blind, randomised, placebo-controlled study

(2013) A. Tursi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The role of IL-15 in gastrointestinal diseases: A bridge between innate and adaptive immune response

(2013) Danilo Pagliari et al.   CYTOKINE & GROWTH FACTOR REVIEWS

A Diet Low in FODMAPs Reduces Symptoms of Irritable Bowel Syndrome

(2013) Emma P. Halmos et al.   GASTROENTEROLOGY

Faecal microbiota composition and host–microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome

(2013) Jonna Jalanka-Tuovinen et al.   GUT

Quantitative Profiling of Gut Microbiota of Children With Diarrhea-Predominant Irritable Bowel Syndrome

(2012) Laura Rigsbee et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Intestinal microbiota in functional bowel disorders: a Rome foundation report

(2012) Magnus Simrén et al.   GUT

Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome

(2011) Mirjana Rajilić–Stojanović et al.   GASTROENTEROLOGY

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Rectal Administration of Lactobacillus casei DG Modifies Flora Composition and Toll-Like Receptor Expression in Colonic Mucosa of Patients with Mild Ulcerative Colitis

(2010) Renata D’Incà et al.   DIGESTIVE DISEASES AND SCIENCES

Postinfectious Irritable Bowel Syndrome

(2009) Robin Spiller et al.   GASTROENTEROLOGY

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

(2008) P. Moayyedi et al.   GUT